Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2363-9024
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI) ; volume:5 ; number:1 ; day:27 ; month:8 ; year:2019 ; pages:1-4 ; date:12.2019
JA clinical reports ; 5, Heft 1 (27.8.2019), 1-4, 12.2019
- Creator
-
Takata, Junko
Arashi, Tomoko
Abe, Ayako
Arai, Shoko
Haruyama, Naoko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40981-019-0275-5
- URN
-
urn:nbn:de:101:1-2020010922130758159734
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takata, Junko
- Arashi, Tomoko
- Abe, Ayako
- Arai, Shoko
- Haruyama, Naoko
- SpringerLink (Online service)
Other Objects (12)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten
Adipositas und Serotonin : vergleichende Untersuchungen verschiedener Stoffwechselparameter sowie der Gewichtsreduktion bei Diabetikern Typ II unter Verabreichung eines Serotonin-reuptake-Inhibitors versus Placebo
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten
Adipositas und Serotonin : vergleichende Untersuchungen verschiedener Stoffwechselparameter sowie der Gewichtsreduktion bei Diabetikern Typ II unter Verabreichung eines Serotonin-reuptake-Inhibitors versus Placebo
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten